NCT02280460

ECMO: Optimization of Its Use

Extracorporeal Membrane Oxygenation(ECMO): Optimization of Its Use

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 921 (actual)
• Sponsor: Renzo Loyaga Rendon · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To create a local registry for ECMO patients.

Detailed description

To create a local registry of retrospective and prospective patients on ECMO at Spectrum Health, Butterworth campus in order to optimize the use of ECMO therapy and to create algorithms to estimate the prognosis. ECMO patients will be compared to a control group of patients. Patient mortality will be assessed in-house, at 48 hours, 3 months, and 1 year after the start of ECMO therapy.

Conditions

• Extracorporeal Membrane Oxygenation Complication

Timeline

• Start date: 2014-09-01
• Primary completion: 2024-05-29
• Completion: 2024-05-29
• First posted: 2014-10-31
• Last updated: 2024-06-05

Locations

1 site across 1 country: United States